The U.K. Office of Fair Trading (OFT) has referred Ryanair’s completed acquisition of a minority stake in Aer Lingus to the Competition Commission. Ryanair purchased 29.82 percent of Aer Lingus in 2006, but the OFT was unable to investigate the deal until 2010 because the European Commission and European Courts were reviewing Ryanair’s bid for outright control of Aer Lingus. The OFT’s investigation was put on hold in January 2011 when Ryanair challenged the probe by arguing that the OFT did not begin its investigation in time. Earlier this month, the U.K. Supreme Court denied Ryanair’s request to appeal a U.K. Court of Appeal ruling that allowed the OFT probe of the airline’s stake in rival Aer Lingus to continue. In rejecting the request, the Court held that Ryanair does not have the right to appeal the decision.
The OFT’s decision to refer Ryanair’s minority holding in Aer Lingus stems from its concerns that Ryanair will be able to use its stake to influence the rival airline: Ryanair and Aer Lingus carry over 80 percent of traffic between the U.K. and Ireland. The OFT believes “there is a realistic prospect that its stake has resulted or will result in a substantial lessening of competition on a number of Ryanair and/or Aer Lingus routes between the UK and Ireland.”
Full content: OFT Press Release
Related content: Antitrust Concerns from Partial Ownership Interest Acquisitions: New Developments in the European Union and the United States
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Federal Court to Hear Case on Trump’s Firing of FTC Democrats
May 20, 2025 by
CPI
UK Government Suffers Third Successive Defeat on Data (Use and Access) Bill
May 20, 2025 by
CPI
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Brazil’s Antitrust Watchdog Expected to Approve Pet Retail Merger Without Conditions
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas